Toxoplasma is equipped with genome sequences for three major lineages (
http://ToxoDB.org) and excellent methods for reverse [
28] and forward genetics [
29]. Several recent studies have taken advantage of these tools and the highly clonal population structure of
Toxoplasma [
30], to map genes in the parasite that control important phenotypic differences between parasite lineages. These studies have lead to the important discovery that ROP proteins play vital roles in modulating host cell signaling and parasite virulence.
One of the most dramatic phenotypes between
Toxoplasma lineages is the difference in their acute virulence in mice: type I strains are uniformly lethal in all strains of mice, while types II and III are relatively nonvirulent, at least in outbred mice [
30]. Taking advantage of this difference, the genetic basis for virulence in the type I lineage was mapped by analysis of progeny from a genetic cross between types I and III. Remarkably, these studies identified a single gene, designated ROP18, as the major determinant of virulence in the type I lineage [
31••] (). The functional role of ROP18 was demonstrated by reverse genetics, taking advantage of the fact that type III strains naturally express extremely low levels of this gene [
31••]. Transgenic parasites of the type III genotype expressing the type I allele of ROP18 showed an increased virulence of ~4 logs [
31••]. ROP18 is one of the few members of the ROP2 clade that contains conserved residues required for S/T kinase activity [
18]. Activity was subsequently demonstrated using
in vitro expressed protein [
32•], and the critical importance of the kinase activity was shown by point mutational analysis in the parasite [
31••]. Insight into the biological function of ROP18 came from studies demonstrating it was secreted into the host cell during invasion, occupied evacuoles, and was ultimately trafficked to the parasite containing vacuole [
31••,
32•] (). The increased virulence of parasites expressing the type I allele of ROP18 is associated with enhanced replication of the parasite (), although other genetic loci also control differences in growth [
31••,
32•]. Type II and III strains also differ in virulence, but owing to their lower pathogenicity these phenotypes can only be appreciated in inbred mouse lines. A comparison of genes required for pathogenesis of type II
vs. III strains by a similar genetic mapping strategy revealed that ROP18, as well as at least 4 other loci, also contribute to pathogenesis in these genetic backgrounds [
33•].
Global analysis of how
Toxoplasma alters host cell transcription led to identification of another secreted rhoptry protein, ROP16, that is targeted to the host cell nucleus [
34••] (). A comparison of strain-specific differences in the induction of host cell transcriptional profiles detected by microarray was used to identify pathways that were differentially affected by parasite genes. This approach took advantage of genetic crosses between type II and III strains to map specific genomic regions in the parasite that mediate changes in host cell transcription ultimately leading to the identification of ROP16 as the effector [
34••]. ROP16 is rapidly injected into host cells during invasion and it makes its way to the host cell nucleus owing to the presence of a nuclear localization sequence, although this element may not be crucial to its function. ROP16 is predicted to be an active S/T kinase and while its direct targets have not been identified, it acts to sustain the phosphorylation of STAT3, a negative regulator of Th1 immune responses. ROP16 is highly polymorphic and genetic analysis reveals that the allele shared by genotypes I and III is effective in mediating sustained phosphorylation of STAT3, while the allele found in type II does not [
34••]. Activation of STAT3/6 may explain the much lower levels of IL-12 that are induced by type I or III versus type II strains following infection of macrophages [
34••,
35]. By modulating host gene expression in this manner, type I and type III strains may be able to avoid detection by the immune system while type II strains seem adapted to trigger early responses, which results in greater immune mediated pathology in mucosal and CNS models of infection in the murine host.